Exposing the molecular heterogeneity of glycosylated biotherapeutics
Abstract The heterogeneity inherent in today’s biotherapeutics, especially as a result of heavy glycosylation, can affect a molecule’s safety and efficacy. Characterizing this heterogeneity is crucial for drug development and quality assessment, but existing methods are limited in their ability to a...
Những tác giả chính: | , , , , , , , , , , , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
Nature Portfolio
2024-04-01
|
Loạt: | Nature Communications |
Truy cập trực tuyến: | https://doi.org/10.1038/s41467-024-47693-8 |